Johnson & Johnson (NYSE: JNJ) is a global healthcare conglomerate with a rich history spanning over 135 years. Founded in 1886, the company has established itself as a leader in the pharmaceutical, medical device, and consumer healthcare industries.
As of March 8, 2023, Johnson & Johnson stock traded at $171.11, with a market capitalization of approximately $450 billion. The stock has a 52-week range of $153.38 to $185.56. Over the past year, JNJ shares have gained 3.2%.
In 2022, Johnson & Johnson's revenue reached $95.7 billion, a 2.3% increase from the previous year. Net income was $20.4 billion, representing an increase of 1.4%. Earnings per share (EPS) stood at $9.26.
The company's balance sheet is strong, with $33.8 billion in cash and cash equivalents and $77.1 billion in total assets. Johnson & Johnson also has a low debt-to-equity ratio of 0.33.
Johnson & Johnson's growth is driven by factors such as:
Investors considering Johnson & Johnson stock should consider the following:
Potential risks and challenges that Johnson & Johnson investors should be aware of include:
On January 24, 2023, Johnson & Johnson held its fourth-quarter 2022 earnings call. Key takeaways included:
Johnson & Johnson is often compared to its peers in the healthcare industry. Here is a table comparing key metrics:
Company | Revenue (2022) | Net Income (2022) | EPS (2022) |
---|---|---|---|
Johnson & Johnson | $95.7 billion | $20.4 billion | $9.26 |
Pfizer | $100.3 billion | $31.0 billion | $6.41 |
Merck | $59.3 billion | $16.4 billion | $7.83 |
According to TipRanks, Johnson & Johnson stock has a consensus "Hold" rating from analysts. The average price target for the stock is $179.92, implying a potential upside of 5.2%.
Technical analysts indicate that the 50-day moving average for Johnson & Johnson stock is currently at $170.62, while the 200-day moving average is at $166.34. The stock appears to have been trending sideways over the past few months.
1. What is the dividend yield of Johnson & Johnson stock?
As of March 8, 2023, the dividend yield of Johnson & Johnson stock is approximately 2.78%.
2. Does Johnson & Johnson have a strong balance sheet?
Yes, Johnson & Johnson has a strong balance sheet with a low debt-to-equity ratio of 0.33.
3. Is Johnson & Johnson stock considered a defensive investment?
Yes, Johnson & Johnson stock is often considered a defensive investment due to its consistent revenue and earnings growth profile.
4. What are Johnson & Johnson's growth strategies?
Johnson & Johnson's growth strategies include pharmaceutical innovation, medical device advancements, and expansion into emerging markets.
5. What are some potential risks associated with investing in Johnson & Johnson stock?
Potential risks include competition, regulatory challenges, and currency fluctuations.
6. What is the consensus analyst recommendation for Johnson & Johnson stock?
The consensus analyst recommendation for Johnson & Johnson stock is "Hold."
7. What is the average price target for Johnson & Johnson stock?
The average price target for Johnson & Johnson stock is $179.92.
8. What is the technical outlook for Johnson & Johnson stock?
The technical outlook for Johnson & Johnson stock is sideways, with the stock trending between its 50-day and 200-day moving averages.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-10-17 14:22:43 UTC
2024-12-22 06:53:37 UTC
2024-12-21 19:22:35 UTC
2024-12-22 08:47:55 UTC
2024-12-22 08:48:16 UTC
2024-12-22 18:11:22 UTC
2024-12-24 00:58:21 UTC
2024-12-08 06:18:48 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:31 UTC
2025-01-04 06:15:28 UTC
2025-01-04 06:15:28 UTC